Also from this source

You just read:

Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011

News provided by

Amylin Pharmaceuticals, Inc. , Eli Lilly and Company

Sep 12, 2011, 07:00 ET